{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:06:22Z","timestamp":1791421582085,"version":"4.3.3"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01067946"],"award-info":[{"award-number":["R01067946"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jaci.2013.07.020","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T19:04:08Z","timestamp":1377630248000},"page":"515-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":490,"title":["Natural killer cell deficiency"],"prefix":"10.1016","volume":"132","author":[{"given":"Jordan S.","family":"Orange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2013.07.020_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.it.2013.02.005","article-title":"Natural killer cells: walking three paths down memory lane","volume":"34","author":"Min-Oo","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2014a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.immuni.2005.01.013","article-title":"A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells","volume":"22","author":"Freud","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.07.020_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2013.07.020_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-032712-100001","article-title":"Control of human viral infections by natural killer cells","volume":"31","author":"Jost","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.coi.2010.11.005","article-title":"Viral evasion of T\u00a0cell immunity: ancient mechanisms offering new applications","volume":"23","author":"Horst","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri3370","article-title":"Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution","volume":"13","author":"Parham","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.mib.2010.05.011","article-title":"Modulation of natural killer cell activity by viruses","volume":"13","author":"Lisnic","year":"2010","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jaci.2013.07.020_bib12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/35059110","article-title":"Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells","volume":"409","author":"Mandelboim","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.07.020_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/07853890.2013.792495","article-title":"Regulation of self-ligands for activating natural killer cell receptors","volume":"45","author":"Lam","year":"2013","journal-title":"Ann Med"},{"key":"10.1016\/j.jaci.2013.07.020_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nri2381","article-title":"Formation and function of the lytic NK-cell immunological synapse","volume":"8","author":"Orange","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"issue":"suppl","key":"10.1016\/j.jaci.2013.07.020_bib16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S1286-4579(02)00038-2","article-title":"Human natural killer cell deficiencies and susceptibility to infection","volume":"4","author":"Orange","year":"2002","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jaci.2013.07.020_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/ACI.0b013e3280106b65","article-title":"Human natural killer cell deficiencies","volume":"6","author":"Orange","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI62620","article-title":"Unraveling human natural killer cell deficiency","volume":"122","author":"Orange","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.07.020_bib20","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s00018-011-0799-y","article-title":"Insights into NK cell biology from human genetics and disease associations","volume":"68","author":"Wood","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2013.07.020_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri3369","article-title":"Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions","volume":"13","author":"Brennan","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe herpesvirus infections in an adolescent without natural killer cells","volume":"320","author":"Biron","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2013.07.020_bib23","first-page":"58","article-title":"Recalcitrant trichophytic granuloma associated with NK-cell deficiency in a SLE patient treated with corticosteroid","volume":"11","author":"Akiba","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.020_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0091-6749(90)90155-W","article-title":"A patient with simultaneous absence of \u201cclassical\u201d natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset","volume":"85","author":"Ballas","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1542\/peds.113.1.136","article-title":"A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells","volume":"113","author":"Bernard","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2013.07.020_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1086\/503269","article-title":"A\u00a0novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8","volume":"78","author":"Eidenschenk","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2013.07.020_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jpeds.2004.11.022","article-title":"Fatal varicella associated with selective natural killer cell deficiency","volume":"146","author":"Etzioni","year":"2005","journal-title":"J Pediatr"},{"issue":"suppl","key":"10.1016\/j.jaci.2013.07.020_bib28","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.clim.2009.03.177","article-title":"Classical natural killer cell deficiency (CNKD): a new case","volume":"131","author":"Min","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jpeds.2005.06.028","article-title":"Natural killer cell deficiencies and severe varicella infection","volume":"148","author":"Notarangelo","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2013.07.020_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-2478(00)00169-3","article-title":"Strong \u03b1\u03b2 and \u03b3\u03b4 TCR response in a patient with disseminated mycobacterium avium infection and lack of NK cells and monocytopenia","volume":"72","author":"Wendland","year":"2000","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2013.07.020_bib31","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1182\/blood-2011-10-385377","article-title":"Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency","volume":"119","author":"Shaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib32","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V98.3.877","article-title":"Defective expression of the interleukin-2\/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency","volume":"98","author":"Gilmour","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib33","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","article-title":"Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset","volume":"121","author":"Mace","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib34","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib35","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib36","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib37","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2011-06-365049","article-title":"Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"118","author":"Cuellar-Rodriguez","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib38","first-page":"672","article-title":"GATA2 deficiency: extended clinical phenotype in 57 patients","volume":"33","author":"Spinner","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI61014","article-title":"Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency","volume":"122","author":"Gineau","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.07.020_bib40","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1172\/JCI60224","article-title":"MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans","volume":"122","author":"Hughes","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.07.020_bib41","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/MMBR.00019-09","article-title":"The Mcm complex: unwinding the mechanism of a replicative helicase","volume":"73","author":"Bochman","year":"2009","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.jaci.2013.07.020_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng1936","article-title":"A\u00a0viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice","volume":"39","author":"Shima","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2013.07.020_bib43","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.4049\/jimmunol.177.12.8835","article-title":"Familial NK cell deficiency associated with impaired IL-2- and IL-15-dependent survival of lymphocytes","volume":"177","author":"Eidenschenk","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-3476(82)80572-6","article-title":"A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections","volume":"100","author":"Fleisher","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2013.07.020_bib45","doi-asserted-by":"crossref","first-page":"e51677","DOI":"10.1371\/journal.pone.0051677","article-title":"Human natural killer cell maturation defect supports in\u00a0vivo CD56(bright) to CD56(dim) lineage development","volume":"7","author":"Domaica","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2013.07.020_bib46","first-page":"323","article-title":"Natural killer cell immunodeficiency in siblings: defective killing in the absence of natural killer cytotoxic factor activity in natural killer and lymphokine-activated killer cytotoxicities","volume":"85","author":"Komiyama","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2013.07.020_bib47","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/infdis\/jis701","article-title":"Natural killer cell functional defects in pediatric patients with severe and recurrent herpesvirus infections","volume":"207","author":"Ornstein","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2013.07.020_bib48","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/infdis\/147.6.1030","article-title":"Correlation between low natural killing of fibroblasts infected with herpes simplex virus type 1 and susceptibility to herpesvirus infections","volume":"147","author":"Lopez","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2013.07.020_bib49","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V88.8.3022.bloodjournal8883022","article-title":"Identification of an unusual Fcg receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections","volume":"88","author":"de Vries","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib50","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2249.1996.tb08295.x","article-title":"Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II)","volume":"103","author":"Jawahar","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib51","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1172\/JCI64837","article-title":"Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity","volume":"122","author":"Grier","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.07.020_bib52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1172\/JCI26217","article-title":"Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis","volume":"116","author":"Risma","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.07.020_bib53","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jaci.2006.04.023","article-title":"Recalcitrant warts, associated with natural killer cell dysfunction, treated with systemic IFN-alpha","volume":"118","author":"Cac","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib54","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.4049\/jimmunol.157.4.1576","article-title":"The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding","volume":"157","author":"Tamm","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib55","first-page":"435","article-title":"The loss of the CD16 B73.1\/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L\/R\/H polymorphism","volume":"26","author":"Lenart","year":"2010","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jaci.2013.07.020_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/brbi.2000.0597","article-title":"The relationship of depression and stressors to immunological assays: a meta-analytic review","volume":"15","author":"Zorrilla","year":"2001","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jaci.2013.07.020_bib57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0300-483X(02)00613-3","article-title":"NK-cell activity in immunotoxicity drug evaluation","volume":"185","author":"Cederbrant","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.jaci.2013.07.020_bib58","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2012-06-437012","article-title":"Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling","volume":"121","author":"James","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib59","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jaci.2012.12.1568","article-title":"Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency","volume":"131","author":"Mizesko","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib60","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2013.07.020_bib61","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3476(97)70199-9","article-title":"Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants","volume":"130","author":"Buckley","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2013.07.020_bib62","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1182\/blood-2003-06-2104","article-title":"Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation","volume":"103","author":"Roberts","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/pbc.23160","article-title":"Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene","volume":"58","author":"Goldman","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaci.2013.07.020_bib64","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1542\/peds.2012-0899","article-title":"Severe combined immunodeficiency resulting from mutations in MTHFD1","volume":"131","author":"Keller","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2013.07.020_bib65","doi-asserted-by":"crossref","first-page":"e1584","DOI":"10.1542\/peds.2005-2882","article-title":"Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation","volume":"118","author":"Bernasconi","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2013.07.020_bib66","first-page":"151","article-title":"Humoral and cellular immune dysfunction in a patient with Bloom's syndrome and recurrent infections","volume":"28","author":"Etzioni","year":"1989","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib67","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.23435","article-title":"Immunological profile of Fanconi anemia: a multicentric retrospective analysis of 61 patients","volume":"88","author":"Korthof","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2013.07.020_bib68","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2141.2002.03822.x","article-title":"A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome","volume":"119","author":"Cossu","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2013.07.020_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2013.07.020_bib70","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2007-02-074468","article-title":"Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients","volume":"110","author":"Bryceson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib71","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells","volume":"119","author":"Cote","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.07.020_bib72","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/mgme.1999.2927","article-title":"Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome","volume":"68","author":"Introne","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jaci.2013.07.020_bib73","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1182\/blood-2009-06-225359","article-title":"Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity","volume":"114","author":"Wood","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib74","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaci.2007.08.039","article-title":"Novel insights from adaptor protein 3 complex deficiency","volume":"120","author":"Badolato","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib75","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood-2012-01-404350","article-title":"Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome","volume":"119","author":"Badolato","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib76","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1182\/blood-2005-03-1140","article-title":"A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity","volume":"107","author":"Meade","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib77","doi-asserted-by":"crossref","first-page":"11351","DOI":"10.1073\/pnas.162376099","article-title":"Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses","volume":"99","author":"Orange","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.07.020_bib78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1084\/jem.20110896","article-title":"A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP","volume":"209","author":"Lanzi","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.020_bib79","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1182\/blood-2011-03-344846","article-title":"Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity","volume":"118","author":"Sanborn","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib80","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood-2012-02-410795","article-title":"Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III","volume":"120","author":"Gruda","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib81","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4049\/jimmunol.165.6.2932","article-title":"Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome","volume":"165","author":"Tangye","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib82","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","article-title":"XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib83","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI37901","article-title":"Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation","volume":"119","author":"Huck","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.07.020_bib84","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cellsig.2007.11.016","article-title":"Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release","volume":"20","author":"Kuehn","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.jaci.2013.07.020_bib85","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1073\/pnas.1013285108","article-title":"ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis","volume":"108","author":"Maul-Pavicic","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.07.020_bib86","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.1102507","article-title":"Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency","volume":"188","author":"Fuchs","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib87","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI0214858","article-title":"Deficient natural killer cell cytotoxicity in patients with IKK-gamma\/NEMO mutations","volume":"109","author":"Orange","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.07.020_bib88","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1104765","article-title":"Requirement for caspase-8 in NF-kappaB activation by antigen receptor","volume":"307","author":"Su","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jaci.2013.07.020_bib89","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2011-01-330571","article-title":"Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation","volume":"118","author":"Vairo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib90","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0198-8859(98)00097-4","article-title":"Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I)","volume":"60","author":"Furukawa","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib91","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2003-06-2114","article-title":"The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients","volume":"103","author":"Markel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib92","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.20111908","article-title":"Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis","volume":"209","author":"Jaeger","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.020_bib93","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2249.1997.284-ce1174.x","article-title":"A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency","volume":"107","author":"Ostenstad","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib94","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Comel-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib95","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1182\/blood-2007-11-122259","article-title":"A role for interleukin-12\/23 in the maturation of human natural killer and CD56+ T cells in\u00a0vivo","volume":"111","author":"Guia","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.020_bib96","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.20111229","article-title":"Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome","volume":"210","author":"Kotlarz","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.020_bib97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature10246","article-title":"Second messenger role for Mg2+ revealed by human T-cell immunodeficiency","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.07.020_bib98","doi-asserted-by":"crossref","first-page":"163ra58","DOI":"10.1126\/scitranslmed.3004430","article-title":"Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses","volume":"4","author":"Yang","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2013.07.020_bib99","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.020_bib100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2249.2006.03221.x","article-title":"Impaired interferon-gamma production in response to live bacteria and Toll-like receptor agonists in patients with ataxia telangiectasia","volume":"146","author":"Reichenbach","year":"2006","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913011238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913011238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:40:34Z","timestamp":1758789634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674913011238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0091674913011238"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2013.07.020","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cell deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2013.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}